Zobrazeno 1 - 10
of 15
pro vyhledávání: '"M J, Zervos"'
Publikováno v:
International Journal of Clinical Practice. 61:853-863
The increasing incidence of serious infections because of Gram-positive pathogens and the rising cost in parenteral administration of antimicrobials has inspired the development of a novel antibiotic. Dalbavancin is the first once a week antibiotic w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5d781b98cc9818d039c18291208bb48
https://doi.org/10.1111/j.1742-1241.2007.01318.x
https://doi.org/10.1111/j.1742-1241.2007.01318.x
Autor:
Steven M. Opal, S. Fortna, Antone A. Medeiros, C. B. Sherman, M. J. Zervos, G. Potter-Bynoe, John M. Boyce, J. W. Chow, R. L. C. Romulo
Publikováno v:
Journal of Clinical Microbiology. 32:1148-1153
Enterococcus faecium strains resistant to ampicillin, high levels of gentamicin, and vancomycin but susceptible to teicoplanin (vanB class vancomycin resistance) were recovered from 37 patients during an outbreak involving a 250-bed university-affili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9b9922653f4476bf7f2485facd0be6
https://doi.org/10.1128/jcm.32.5.1148-1153.1994
https://doi.org/10.1128/jcm.32.5.1148-1153.1994
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 13:293-298
In a randomized prospective study ampicillin/sulbactam and cefamandole were compared in the therapy of patients hospitalized with community acquired pneumonia. Patients receiving ampicillin/sulbactam (n = 37) and cefamandole (n = 38) were similar wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f7234064374256858830ca01b2348d1
https://doi.org/10.1007/bf01974603
https://doi.org/10.1007/bf01974603
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(4)
The increasing prevalence of drug-resistant gram-positive cocci, such as methicillin-resistant Staphylococcus aureus, has underscored the need for new agents for the treatment of this type of infection. Dalbavancin, a new lipoglycopeptide, has the de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4589035c5e36f1a93511ecadaefd6e92
https://pubmed.ncbi.nlm.nih.gov/18199045
https://pubmed.ncbi.nlm.nih.gov/18199045
Publikováno v:
Journal of Clinical Microbiology. 29:2663-2665
A prospective study identified 9 (32%) of 28 ampicillin-resistant (MIC greater than or equal to 16 micrograms/ml) enterococcus isolates as Enterococcus raffinosus. A case-control study found no significant differences with respect to underlying disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0862fc8203a295428ad01a81d9e8a3f
https://doi.org/10.1128/jcm.29.11.2663-2665.1991
https://doi.org/10.1128/jcm.29.11.2663-2665.1991
Publikováno v:
The Journal of antimicrobial chemotherapy. 42(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::92cc22148cf3790726ee8749eb4a7c4f
https://pubmed.ncbi.nlm.nih.gov/10052913
https://pubmed.ncbi.nlm.nih.gov/10052913
Autor:
T L, Smith, M L, Pearson, K R, Wilcox, C, Cruz, M V, Lancaster, B, Robinson-Dunn, F C, Tenover, M J, Zervos, J D, Band, E, White, W R, Jarvis
Publikováno v:
The New England journal of medicine. 340(7)
Since the emergence of methicillin-resistant Staphylococcus aureus, the glycopeptide vancomycin has been the only uniformly effective treatment for staphylococcal infections. In 1997, two infections due to S. aureus with reduced susceptibility to van
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8d034c38633a79c614030e2c371e322f
https://pubmed.ncbi.nlm.nih.gov/10409039
https://pubmed.ncbi.nlm.nih.gov/10409039
Autor:
M. J. Zervos, M. Ionescu
Publikováno v:
Yearbook of Intensive Care and Emergency Medicine ISBN: 9783540652885
Antimicrobial resistance is an increasing problem. There are now microorganisms resistant to all available treatment options [1–8]. Important antimicrobial resistance problems in Gram-positive bacteria include penicillin resistance in Streptococcus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d21d4cbfa7511caa4dafb37caf91729d
https://doi.org/10.1007/978-3-662-13453-5_12
https://doi.org/10.1007/978-3-662-13453-5_12
Autor:
M J, Zervos, J A, Vazquez
Publikováno v:
Clinics in laboratory medicine. 16(1)
Fungal infections, most of which are caused by the Candida species, are an increasing problem in the immunocompromised host. The clinical manifestations of Candida infections include disseminated candidiasis, oral and esophageal infections, focal hep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3302e05f29401dd4e48e03e9ab7421dd
https://pubmed.ncbi.nlm.nih.gov/8867584
https://pubmed.ncbi.nlm.nih.gov/8867584
Publikováno v:
Infectious agents and disease. 4(4)
The epidemiology of nosocomial Candida is complex. Molecular DNA analysis has provided useful information in the study of nosocomial infection. The most important inpatient hospital reservoir is colonized patients. Most patients are infected with str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dac43fea1032b6fc2a319ab3382c6e5e
https://pubmed.ncbi.nlm.nih.gov/8665088
https://pubmed.ncbi.nlm.nih.gov/8665088